What to know first
- GOLD adds apomorphine and oxytocin; this Hard Mint includes B12.
- A four-ingredient formula is not evidence of a better result.
- Public pricing is not a matched quote for the two prescriptions.
These product reviews examine public formulation information, research, and service terms. We have not ordered the treatments, tested their effects, or audited patient care. How we research.
Compare the named formulations
On smaller screens, scroll the table sideways.
| Detail | BlueChew GOLD | Hims 3-in-1 Hard Mints |
|---|---|---|
| Listed ingredients | Sildenafil, tadalafil, apomorphine, oxytocin | Sildenafil, tadalafil, vitamin B12 |
| Format | Sublingual tablet | Mint-flavored chew |
| Regulatory status | Compounded; not FDA-approved | Compounded; not FDA-approved |
| Clinical question | Why add apomorphine and oxytocin? | Why this combination and these strengths, including B12? |
Sources: GOLD product information, Hims’ catalog, and Hard Mints formula information. Neither column describes the entire provider’s range. Hims’ tadalafil-only chews and BlueChew’s MAX have separate ingredient lists.
Ask for the actual strengths and pharmacy directions. A product name or number of ingredients cannot establish dose equivalence between a chew and a sublingual tablet.
The extra ingredients need their own rationale
GOLD’s apomorphine and oxytocin change the medication questions. Research on each ingredient is not a test of the four-drug mixture. A statement about arousal, intimacy, or subjective experience also does not necessarily measure erection firmness.
The oxytocin study reviewed involved healthy couples and an intranasal route. It did not establish an improved erection outcome for GOLD or compare it with Hard Mints. A single-ingredient apomorphine trial likewise did not test GOLD. We reviewed indexed abstracts.
For Hard Mints, B12 should not be treated as proof of superior sexual performance. Ask whether evidence applies to the whole formulation, the actual route and strengths, and the patient group being treated.
Neither headline gives a clean price contest
Hims’ current catalog advertises 3-in-1 Hard Mints from $30 monthly, while its separate chewable page uses a $6-per-use starting figure for selected sildenafil/tadalafil mints. Those numbers do not establish a single matched quantity or upfront commitment.
BlueChew’s GOLD cost article gives approximate unit examples of $18.28 for a six-tablet monthly pack and $11.65 for an 18-tablet quarterly pack. Its general cost article gives different approximate GOLD examples. We have not verified which offer applies to a particular checkout.
Obtain the exact formulation, quantity, amount due now, shipping, taxes, and renewal for each prescription. A price comparison should label source disagreement and missing plan details, rather than silently choosing the cheapest number from each site.
Administration and timing are part of the comparison
Follow the pharmacy’s directions for the actual chew or sublingual product. Do not transfer chewing or swallowing instructions from one product to the other. Ask about inactive ingredients, storage, and what to do if the product does not behave as expected.
A claimed fast onset is an average or a defined study result, not a redosing instruction. To compare timing fairly, the measurement would need the same start point and outcome. We did not verify a controlled head-to-head trial establishing a timing or efficacy winner between these finished products.
Evaluate combinations separately from individual ingredients
BlueChew GOLD and Hims Hard Mints are compounded products, not FDA-approved finished medicines. Approval of a conventional sildenafil or tadalafil tablet does not validate a different multi-ingredient formulation. A claim about faster absorption is also not proof of better outcomes for every patient.
GOLD includes two PDE5 inhibitors, and some Hard Mints formulas do as well. Standard tadalafil labeling advises against combining tadalafil with other PDE5 inhibitors. Ask the clinician why the proposed combination is appropriate, what alternatives exist, and what interactions need attention. Do not mix products from the two services yourself.
Cancellation, plan changes, and geographic access
On smaller screens, scroll the table sideways.
| Action | BlueChew | Hims |
|---|---|---|
| Stop future billing | Account hold options include one-order skip or indefinite stop; cancellation policy asks for at least 24 hours before renewal. | Cancel the selected subscription at least 48 hours before the next order date. |
| Change a plan | Account FAQ asks for at least 48 hours because treatment changes require provider review. | Changes or rescheduling should be made at least 48 hours before the next order. |
| Order already processing | Plan changes do not affect orders already in process. | Ending the subscription does not cancel an order processing or shipped. |
| Prescription return/refund | Prescription returns are not accepted; contact support about concerns. | No guaranteed refund after pharmacy processing. |
See BlueChew’s account instructions and policy, and Hims’ cancellation and refund guidance. A treatment change, a skipped order, and a permanent cancellation should be checked as separate outcomes.
Geography also matters. BlueChew’s shipping FAQ excludes North Dakota and lists specific supported U.S. territories. Check eligibility at your own address rather than assuming that a national advertisement means every product is available everywhere. We have not completed eligibility checks for individual patients or states.
Three ways to use this comparison
If swallowing tablets is the main difficulty: tell the clinician what happens when you try to swallow medication. Ask about suitable formats and why a particular compounded option is proposed. A more complex formula is not automatically necessary simply because the route changes.
If a prior medicine was disappointing: bring the medication name, prescribed dose, instructions, response, and side effects. The next step may involve reviewing use, health factors, or the diagnosis rather than choosing the product with the largest ingredient count.
If cost is the main constraint: ask about conventional generic options as well as compounded products, then compare the same quantities and payment intervals. Set a reminder before the displayed processing date if you plan to reassess treatment. These are ways to organize a clinician discussion, not recommendations to select or dose a particular medicine yourself.
Questions for follow-up care
Ask how the clinician would simplify or change the formula if there is a side effect, inadequate response, or a new interacting medicine. Starting multiple ingredients together can make it harder to know which caused a change. That is a reason for a clear monitoring plan.
Clinical adjustment and subscription management are separate. Check the next shipment and save cancellation or rescheduling confirmations. A provider message about symptoms does not guarantee that a processing order will be stopped or refunded.
We have not ordered either treatment, tested its contents, or measured clinical care. This comparison uses public formulation and policy documents; it is not a patient-experience score.
The individual product reviews
BlueChew GOLD review · Hims 3-in-1 Hard Mints review
For formulas without GOLD’s apomorphine and oxytocin, compare BlueChew MAX and Ro Sparks. Conventional Hims Sildenafil is a different single-ingredient tablet category.
Frequently asked questions
Is GOLD a direct substitute for Hard Mints?
No. The ingredient lists and dosage forms differ. A clinician should assess a switch and provide instructions.
Does a four-drug product work better than a three-ingredient mint?
Ingredient count is not a clinical outcome. The exact finished products need relevant evidence and a patient-specific rationale.
Can a new BlueChew customer choose GOLD?
A reviewed provider notice lists GOLD among new-customer options, subject to assessment. Other BlueChew products have separate availability restrictions.
Do the public prices establish a winner?
No. The offers have different formulas and incomplete or conflicting plan context. A matched quote is needed.
Compare formulas, formats, and full costs.
Use the exact product and prescription to prepare a conversation with your clinician.
Compare ED productsSources & notes
Sources checked October 7, 2026. Provider pages establish what is advertised, not independently verified clinical outcomes.
- Hims: current ED treatment catalog
Provider catalog; individual named offers and starting prices - Hims: Hard Mints formulation safety library
Provider formulation document; includes options not confirmed in the main catalog - BlueChew: product-specific approximate costs
Provider price examples; approximate and not necessarily consistent with other offer pages - Hims Support: canceling a subscription
Provider policy; 48-hour notice and orders already processing - Hims Support: refund policy
Provider policy; no guaranteed refund after pharmacy processing - BlueChew: GOLD published cost breakdown
Provider marketing article; approximate price examples, not a checkout quote - BlueChew: account and subscription questions
Provider policy; plan changes, one-order skips, and indefinite holds - BlueChew: shipping and delivery questions
Provider policy; destination availability, shipping, and renewal terms - BlueChew: returns and refunds policy
Provider policy; prescription returns and 24-hour cancellation notice - Dula et al. (2001): sublingual apomorphine crossover trial
Primary randomized trial; single-ingredient apomorphine, abstract reviewed via NCBI - Behnia et al. (2014): intranasal oxytocin in couples
Primary study; 29 healthy couples, different route and population from GOLD, abstract reviewed via NCBI - Hims: Hard Mints chewable ED medicines
Provider source; compounded formulations and advertised starting prices - BlueChew: GOLD product and plan information
Provider source; four-ingredient compounded formulation - DailyMed: Tadalafil prescribing information, including section 5.11
Prescribing label; not evidence for the 4Play combination